Unknown

Dataset Information

0

Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I.


ABSTRACT: Oxidative damage from elevated production of reactive oxygen species (ROS) contributes to ischemia-reperfusion injury in myocardial infarction and stroke. The mechanism by which the increase in ROS occurs is not known, and it is unclear how this increase can be prevented. A wide variety of nitric oxide donors and S-nitrosating agents protect the ischemic myocardium from infarction, but the responsible mechanisms are unclear. Here we used a mitochondria-selective S-nitrosating agent, MitoSNO, to determine how mitochondrial S-nitrosation at the reperfusion phase of myocardial infarction is cardioprotective in vivo in mice. We found that protection is due to the S-nitrosation of mitochondrial complex I, which is the entry point for electrons from NADH into the respiratory chain. Reversible S-nitrosation of complex I slows the reactivation of mitochondria during the crucial first minutes of the reperfusion of ischemic tissue, thereby decreasing ROS production, oxidative damage and tissue necrosis. Inhibition of complex I is afforded by the selective S-nitrosation of Cys39 on the ND3 subunit, which becomes susceptible to modification only after ischemia. Our results identify rapid complex I reactivation as a central pathological feature of ischemia-reperfusion injury and show that preventing this reactivation by modification of a cysteine switch is a robust cardioprotective mechanism and hence a rational therapeutic strategy.

SUBMITTER: Chouchani ET 

PROVIDER: S-EPMC4019998 | biostudies-literature | 2013 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications


Oxidative damage from elevated production of reactive oxygen species (ROS) contributes to ischemia-reperfusion injury in myocardial infarction and stroke. The mechanism by which the increase in ROS occurs is not known, and it is unclear how this increase can be prevented. A wide variety of nitric oxide donors and S-nitrosating agents protect the ischemic myocardium from infarction, but the responsible mechanisms are unclear. Here we used a mitochondria-selective S-nitrosating agent, MitoSNO, to  ...[more]

Similar Datasets

| S-EPMC1383712 | biostudies-other
| S-EPMC5749586 | biostudies-literature
| S-EPMC4168224 | biostudies-literature
| S-EPMC8577438 | biostudies-literature
| S-EPMC5207242 | biostudies-literature
| S-EPMC6208296 | biostudies-literature
| S-EPMC3431704 | biostudies-literature
| S-EPMC6731384 | biostudies-literature
| S-EPMC4039430 | biostudies-literature
2018-07-11 | PXD009079 | Pride